A
The startup has developed a dialysis-machine agnostic platform that enables patients to perform hemodialysis independently and affordably, while also designing a device that enhances vascular access reliability and minimizes cannulation pain. This approach aims to reduce the overall costs of dialysis and preserve the health of arteriovenous fistulas for individuals with kidney failure.
Singapore, Singapore
Updated 2 months ago
Funding
$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a dialysis-machine agnostic platform that enables patients to perform hemodialysis independently and affordably, while also designing a device that enhances vascular access reliability and minimizes cannulation pain. This approach aims to reduce the overall costs of dialysis and preserve the health of arteriovenous fistulas for individuals with kidney failure.